Obinutuzumab Followed by Gemcitabine/Glofitamab/Oxaliplatin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of obinutuzumab followed by gemcitabine, glofitamab and oxaliplatin that can be used for the treatment of diffuse large B-cell lymphoma (DLBCL).

**Synonyms:** - Gazyva Followed by GemOx Plus Columvi - Gazyva Followed by GemOx-Columvi - Gazyva Followed by Gemcitabine/Oxaliplatin Plus Columvi - GemOx-Glofitamab-Obinutuzumab - GemOx/Glofitamab-gxbm/Obinutuzumab - GemOx/Glofitamab/Obinutuzumab Regimen - GemOx/Obinutuzumab/Glofitamab - Gemcitabine/Glofitamab/Obinutuzumab/Oxaliplatin Regimen - Obinutuzumab Followed by GemOx/Glofitamab Regimen - Obinutuzumab Followed by GemOx/Glofitamab-gxbm Regimen